(+/-)-6-Methyl-2-(3-((2-(trifluoromethyl)phenoxy)methyl)-pyrrolidin-1-yl)pyrimidine-4-carboxamide

ID: ALA4759066

Chembl Id: CHEMBL4759066

PubChem CID: 162658767

Max Phase: Preclinical

Molecular Formula: C18H19F3N4O2

Molecular Weight: 380.37

Molecule Type: Unknown

Associated Items:

Names and Identifiers

Canonical SMILES:  Cc1cc(C(N)=O)nc(N2CCC(COc3ccccc3C(F)(F)F)C2)n1

Standard InChI:  InChI=1S/C18H19F3N4O2/c1-11-8-14(16(22)26)24-17(23-11)25-7-6-12(9-25)10-27-15-5-3-2-4-13(15)18(19,20)21/h2-5,8,12H,6-7,9-10H2,1H3,(H2,22,26)

Standard InChI Key:  OJZIIBZLOVQKAP-UHFFFAOYSA-N

Alternative Forms

  1. Parent:

    ALA4759066

    ---

Associated Targets(Human)

RBP4 Tchem Plasma retinol-binding protein (718 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID
TTR Tclin Transthyretin (2847 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 380.37Molecular Weight (Monoisotopic): 380.1460AlogP: 2.81#Rotatable Bonds: 5
Polar Surface Area: 81.34Molecular Species: NEUTRALHBA: 5HBD: 1
#RO5 Violations: HBA (Lipinski): 6HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 13.68CX Basic pKa: 2.73CX LogP: 2.79CX LogD: 2.79
Aromatic Rings: 2Heavy Atoms: 27QED Weighted: 0.86Np Likeness Score: -1.58

References

1. Cioffi CL,Muthuraman P,Raja A,Varadi A,Racz B,Petrukhin K.  (2020)  Discovery of Bispecific Antagonists of Retinol Binding Protein 4 That Stabilize Transthyretin Tetramers: Scaffolding Hopping, Optimization, and Preclinical Pharmacological Evaluation as a Potential Therapy for Two Common Age-Related Comorbidities.,  63  (19): [PMID:32878437] [10.1021/acs.jmedchem.0c00996]

Source